CA - Theratechnologies beats top-line and bottom-line estimates; initiates FY24 outlook
2024-02-21 07:40:44 ET
More on Theratechnologies
- Theratechnologies says FDA rejected new Egrifta version
- Theratechnologies stock slides as Egrifta review runs beyond FDA target date
- Seeking Alpha’s Quant Rating on Theratechnologies
- Historical earnings data for Theratechnologies
- Financial information for Theratechnologies